In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods
- 1 February 1999
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 33 (2) , 75-80
- https://doi.org/10.1016/s0732-8893(98)00130-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Influence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized MethodsAntimicrobial Agents and Chemotherapy, 1998
- Treatment of Histoplasmosis with MK-991 (L-743,872)Antimicrobial Agents and Chemotherapy, 1998
- In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)Antimicrobial Agents and Chemotherapy, 1997
- Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosisAntimicrobial Agents and Chemotherapy, 1997
- Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)Antimicrobial Agents and Chemotherapy, 1997
- Treatment of murine Candida krusei or Candida glabrata infection with L-743,872Antimicrobial Agents and Chemotherapy, 1997
- Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformansAntimicrobial Agents and Chemotherapy, 1997
- Treatment of murine disseminated candidiasis with L-743,872Antimicrobial Agents and Chemotherapy, 1997
- In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important moldsAntimicrobial Agents and Chemotherapy, 1997
- Method of reliable determination of minimal lethal antibiotic concentrationsAntimicrobial Agents and Chemotherapy, 1980